Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients
GRPC-DM
The Effect of Golden Rice Cookies With Piper Crocatum Extract on Lipid Profile Control in Patients With Diabetes Mellitus
1 other identifier
interventional
102
1 country
2
Brief Summary
People with diabetes often experience abnormal blood fat levels, known as dyslipidemia, which increase the risk of heart disease and stroke. The aim of the study, researchers are exploring a natural and practical solution through a healthy snack in the form of cookies. These cookies are made from Golden Rice, which is rich in beta-carotene as a natural antioxidant, and Piper crocatum (red betel leaf) extract, which contains polyphenols and flavonoids that may help lower cholesterol, reduce inflammation, and protect blood vessels. In this study, patients with diabetes will consume the cookies for 28 days, and their blood fat levels will be measured before and after the intervention. The results will then be compared with those of a control group who receive the Golden rice cookies without piper crocatum extract. This research aims to show that Golden Rice with Piper crocatum extract cookies can reduce bad cholesterol and triglycerides, increase good cholesterol, and serve as a safe, affordable, and acceptable food option to support daily diabetes care. If successful, this approach may offer patients and families a simple way to help prevent complications and improve quality of life, alongside regular treatment and lifestyle changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2025
CompletedStudy Start
First participant enrolled
October 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedFirst Posted
Study publicly available on registry
December 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 8, 2025
December 1, 2025
1 month
September 30, 2025
December 5, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in total Cholesterol (mg/dL)
Serum total cholesterol will be measured to assess the effect of Golden Rice cookies enriched with Piper crocatum extract on lipid control in patients with diabetes mellitus.
Baseline (Day 0) and after 28 days of intervention
Change in Low-Density Lipoprotein (LDL) Cholesterol (mg/dL)
LDL cholesterol levels will be measured to evaluate changes following the 28-day intervention
Baseline (Day 0) to Day 28
Change in High-Density Lipoprotein (HDL) Cholesterol (mg/dL)
HDL cholesterol levels will be measured to determine improvement in protective lipid fractions.
Baseline (Day 0) to Day 28
Change in Triglycerides (mg/dL)
Serum triglyceride levels will be measured to assess metabolic lipid response to the intervention.
Baseline (Day 0) to Day 28
Secondary Outcomes (2)
Participant adherence Rate (%)
Baseline to Day 28
Incidence of Adverse Events (Number of Participants)
Baseline to Day 28
Study Arms (2)
Golden Rice cookies With Piper Crocatum extract
EXPERIMENTALParticipants will receive Golden Rice cookies enriched with Piper crocatum extract as a daily dietary supplement for 28 consecutive days. The cookies are formulated as a functional food, providing β-carotene from Golden Rice and polyphenols from Piper crocatum, which have antioxidant, anti-inflammatory, and lipid-modulating properties. The intervention aims to improve lipid metabolism by reducing total cholesterol, LDL, and triglycerides while increasing HDL levels in patients with Diabetes Mellitus.
Active Comparator (Control)
ACTIVE COMPARATORParticipants will receive Golden Rice cookies without Piper crocatum extract, identical in appearance and packaging to the intervention cookies, for 28 consecutive days. This control is designed to maintain participant blinding and to serve as a comparison for evaluating the specific effects of Piper crocatum extract on lipid profile outcomes.
Interventions
Golden Rice cookies enriched with Piper crocatum extract, formulated as a functional food containing β-carotene and polyphenols with antioxidant, anti-inflammatory, and lipid-modulating properties. Participants will consume the cookies daily for 28 consecutive days in addition to their standard diabetes management. This intervention is designed to improve lipid metabolism and reduce dyslipidemia in patients with Diabetes Mellitus.
Placebo cookies without Golden Rice or Piper crocatum extract, identical in appearance, taste, and packaging to the intervention cookies. Participants will consume placebo cookies daily for 28 consecutive days along with their standard diabetes management. This placebo is used to maintain participant blinding and provide a valid comparison.
Eligibility Criteria
You may qualify if:
- Adults aged 18-59 years.
- Patients diagnosed with Type 2 Diabetes Mellitus based on medical records at Tambu Primary Health Center.
- Able to read and communicate effectively with healthcare staff.
- Permanent resident in the Tambu area.
- Willing to participate in the intervention and follow-up evaluations for the duration of the study.
You may not qualify if:
- Pregnant or breastfeeding women, or those currently undergoing a pregnancy program.
- Patients with mental health disorders.
- Patients with severe comorbidities affecting lipid metabolism, such as chronic kidney disease (CKD), hepatitis, congestive heart failure, stroke, or acute coronary syndrome within the past 3 months.
- Patients who have consumed herbal supplements or high-dose antioxidants within the last month.
- Patients with severe gastrointestinal disorders, such as chronic diarrhea.
- Patients with a history of allergy to any ingredients used in the study intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Tambu Primary Health Center (Puskesmas Tambu)
Donggala, Central Sulawesi, 94355, Indonesia
RSUD Anutapura Palu
Palu, Central Sulawesi, 94111, Indonesia
Related Publications (3)
Setyawati A, Saleh A, Tahir T, Yusuf S, Syahrul S, Aminuddin A, Raihan M, Jafar N, Hamzah H, Arfian N. Matrix Metalloproteinase-9 Testing of Golden Rice Cookies With Piper Crocatum Active Extract for Preventing Foot Ulcers in Patients With Diabetes: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2024 Feb 29;13:e49940. doi: 10.2196/49940.
PMID: 38422498BACKGROUNDhttps://jppres.com/jppres/pdf/vol13/jppres25.2499_13.6.1847.pdf
RESULTSetyawati A, Wahyuningsih MSH, Nugrahaningsih DAA, Effendy C, Fneish F, Fortwengel G. Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblasts. Saudi J Biol Sci. 2021 Dec;28(12):7257-7268. doi: 10.1016/j.sjbs.2021.08.039. Epub 2021 Aug 19.
PMID: 34867030RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ANDINA SETYAWATI, PhD, S.Kep., Ns., M.Kep.
Hasanuddin University, Faculty of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not be informed about whether they are in the intervention or control group, since both groups will receive packaged cookies that appear identical. Investigators and care providers will know the allocation in order to ensure proper delivery of the intervention, but outcome assessors and laboratory personnel measuring lipid profiles will remain blinded to minimize bias.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- S.Kep.,Ns
Study Record Dates
First Submitted
September 30, 2025
First Posted
December 8, 2025
Study Start
October 20, 2025
Primary Completion
November 30, 2025
Study Completion
December 31, 2025
Last Updated
December 8, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual participant data (IPD) for this study.